119th Congress · House
HR. 1082
Shandra Eisenga Human Cell and Tissue Product Safety Act
committee
Introduced 2025-02-06•Latest 2025-06-24
Origin chamber
House
Cosponsors
1
Latest action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory proceduresCivil actions and liabilityCongressional oversightDepartment of Health and Human ServicesHealthHealth programs administration and fundingHealth promotion and preventive careOrgan and tissue donation and transplantation
Key actions
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Mr. Bilirakis moved to suspend the rules and pass the bill.
- Considered under suspension of the rules. (consideration: CR H2860-2862)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
- Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
- On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
- Motion to reconsider laid on the table Agreed to without objection.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
- Placed on the Union Calendar, Calendar No. 127.
- Committee Consideration and Mark-up Session Held
- Ordered to be Reported by Voice Vote.
- Introduced in House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.